ClinicalTrials.gg
CompletedNCT05300061Updated Mar 29, 2022

Values Interventions for Increasing Engagement With What is Feared in Individuals With Specific Phobias

An interventional study of Personal Values Intervention and Prosocial Values Intervention in Specific Phobia, sponsored by University of Cyprus. Completed at 1 site in Cyprus. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-03-29.

Sponsored by University of Cyprus · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 1 year 2 months after the study started (first participant enrolled Sep 2020, registered Nov 2021).
Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Exposure is considered the therapy of choice for specific phobias (SPs). Nevertheless, therapy engagement is extremely limited. SPs are maintained through avoidance of feared stimuli and as such willingness to approach what is feared constitutes a key factor that could explain limited treatment engagement. Values interventions, a key element of acceptance and commitment therapy (ACT), might be one way to increase engagement, yet to this date limited research exists in this area. For the purposes of the current study, two brief values interventions were developed: (a) a personal and (b) a prosocial one. These will be compared to (c) a no-instructions control in increasing willingness to approach and approach behaviour towards phobic stimuli. Ninety participants with flying phobia will be randomly allocated to one of the three groups. To measure willingness to engage with feared stimuli and approach behaviour two behavioural approach tasks using novel technologies (virtual reality), which aimed to expose participants to situations analogous to real life, were developed. Willingness and behavioural approach towards airplanes at a one month follow up will also be assessed.

Therefore, it is hypothesised that:

  1. Participants in either of the two values intervention groups will have greater willingness to engage and approach behaviour towards feared stimuli compared to those in control, during the study tasks.
  2. Participants in either of the two values intervention groups will have greater willingness to engage and approach behaviour towards feared stimuli compared to those in control at follow up.

    Additionally, as prosocial values provide an evolutionary advantage, the second study aim was to identify if they lead to greater engagement with phobic stimuli compared to personal ones. Therefore, it was also hypothesised that:

  3. Participants in the prosocial values group will have greater willingness to engage and approach behaviour towards feared stimuli compared to those in personal values group, both during the study tasks and at follow up.
  4. Participants in the prosocial values group will have greater willingness to engage and approach behaviour towards feared stimuli compared to those in personal values group at follow up.
02

Conditions studied

  • Specific Phobia

Browse trials for

Keywords

  • Specific Phobia
  • Flying Phobia
  • Exposure Therapy
  • Values Interventions
03

In context

Phobia, Specific

85 studies on the registry are indexed under Phobia, Specific; 13 are open to participants now.

This study's enrollment of 90 is above the median of 74 across 81 interventional studies indexed under Phobia, Specific.

Browse Phobia, Specific studies →

Lead sponsor

University of Cyprus is the lead sponsor of 28 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 or older
  • Meeting the Diagnostic and Statistical Manual for Mental Disorders 5
  • Good knowledge of the Greek language (adequate comprehension level, reading level, and verbal communication)

Exclusion criteria

Exclusion Criteria:

  • Severe heart disease
  • High blood pressure
  • Photosensitive epilepsy
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
90 participants (actual)

Study arms

  • Experimental
    Personal Values Intervention

    Brief personal values intervention

    Behavioral: Personal Values Intervention

  • Experimental
    Prosocial Values Intervention

    Brief prosocial values intervention

    Behavioral: Prosocial Values Intervention

  • No intervention
    Control

    No intervention control

Interventions

  • BehavioralPersonal Values Intervention

    A 15 minute personal values intervention. Aim is to help participants clarify their own values around flying and promote committed action towards airplanes.

  • BehavioralProsocial Values Intervention

    A 15 minute prosocial values intervention. Aim is to help participants clarify their prosocial values around flying and promote committed action towards airplanes.

06

What researchers measure

Primary outcomes

  1. Willingness

    In order to capture willingness to engage with feared stimuli three questions were employed, one question for each study task and one for follow up. For example to capture willingness to engage with the virtual reality behavioural approach task, participants were asked: "How willing are you to participate in a virtual reality task involving airplanes?". Answers for all three questions were rated on a scale from 1 (Not willing at all) to 10 (Extremely willing), with higher scores indicating greater willingness levels (i.e., total score: 1 - 10). This approach for developing willingness questions was based on other studies similarly aiming to capture willingness as part of their outcomes using a brief measure (e.g., Fink-Lamotte et al., 2020).

    Time frame: Day 1 (During experimental tasks)

  2. Virtual Reality Behavioural Approach Task (VR BAT)

    The virtual reality (VR) behavioural approach task was developed for the current study to capture approach behaviour towards airplanes in VR. In total the task included seven steps. Each step depicted a different aspect of flying with associated VR visuals and sounds: 1) airplane stopped engine off, 2) airplane stopped engine running, 3) taxiing, 4) take off, 5) cruising, 6) turbulence and 7) landing, each lasting between 51 and 129 seconds. Approach behaviour was calculated by adding the number of steps participants completed in the VR BAT with total approach behaviour score ranging from 0 to 7.

    Time frame: Day 1 (During experimental tasks)

  3. Behavioural Willingness Assessment (BWA)

    For this task, participants were presented with the option to book a short complementary flight. This was a categorical response variable: Participants could either book a flight or decline to participate. Booking a flight indicated approach behaviour towards airplanes.

    Time frame: Day 1 (During experimental tasks)

  4. Follow up Flying Behaviour

    To measure approach behaviour towards airplanes outside the laboratory setting at a one month follow up, one question was employed ("In the past month, have you come in contact with airplanes in any way, such as taking a flight, or booking flight tickets or hotels abroad?") with a "yes" or "no" response (categorical response variable). An affirmative response indicated approach behaviour towards airplanes.

    Time frame: One month follow up

Secondary outcomes

  1. Avoidance Behaviours

    Total number of avoidance behaviours employed by the participants during the virtual reality behavioural approach task were tallied by the experimenter.

    Time frame: Day 1 (During experimental tasks)

07

Study locations

1 site
  • University of Cyprus
    Nicosia, Non-US/Non-Canadian 1678, Cyprus
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 29, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05300061
Lead sponsor
University of Cyprus
Collaborators
Youth Board of Cyprus
Responsible party
Maria Karekla (Associate Professor, University of Cyprus) — Principal investigator
First posted
Mar 29, 2022
Start date
Sep 1, 2020
Primary completion
May 14, 2021
Completion
May 14, 2021
Last update
Mar 29, 2022

Study contacts

Maria Karekla, PhD
principal investigator · University of Cyprus

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion